Patent Assignment
Reel/Frame 028650/0717
Assignment of Assignor's Interest
Recorded: 2012-07-26
Pages: 8
Assignor
ASTEX PHARMACEUTICALS, INC.
Executed: 2012-07-16
Assignee
TOLERO PHARMACEUTICALS, INC.
9980 SOUTH 300 WEST, SUITE #200, SALT LAKE CITY, UTAH, 84070
Covered Properties
(15)
Imidazo[1,2-Beta]Pyridazine and Pyrazolo[1,5-Alpha]Pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
Pyrimidine-2,4-Diamine Derivatives and Their Use as JAK2 Kinase Inhibitors
Application:
12/040,002 →
Publication:
US 2008/0214558
Axl Kinase Inhibitors
Pyrimidine-2, 4-diamine JAK2 Kinase inhibiting anti-inflammation use
Application:
12/460,820 →
Publication:
US 2010/0029675
Pyrrolopyrimidinyl axl kinase inhibitors
Application:
12/658,433 →
Publication:
US 2010/0204221
Methods and Compounds for Treating Pim-1 Kinase-Expressing Cancer Cells
Application:
12/785,322 →
Publication:
US 2010/0227861
Axl Kinase Inhibitors
Application:
13/183,197 →
Publication:
US 2011/0269772
Imidazo[1,2-B]Pyridazine and Pyrazolo[1,5-a]Pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
IMIDAZO[1,2-b]PYRIDAZINE AND PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
Application:
60/864,566 →
IMIDAZO[1,2-b]PYRIDAZINE AND PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
Application:
60/892,523 →
IMIDAZO[1,2-b]PYRIDAZINE AND PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
Application:
60/957,988 →
[1,2,4]Triazolo[4,3-A]Pyridine Derivatives and Their Use as Protein Kinase Inhibitors
Application:
61/510,207 →
Imidazo[1,2-B]Pyridazine and Pyrazolo[1,5-a]Pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
Application:
61/608,028 →
Imidazo[1,2-B]Pyridazine and Pyrazolo[1,5-a]Pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
Application:
61/632,826 →
Imidazo[1,2-B]Pyridazine and Pyrazolo[1,5-a]Pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
Application:
61/632,834 →
Publication:
US 2012/0058997
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 2, 2007
From: BEARSS, DAVID J.; VANKAYALAPATI, HARIPRASAD; LIU, XIAO-HUI
To: SUPERGEN, INC.
Reel/Frame 018954/0792 →
Assignment of Assignor's Interest
Mar 30, 2007
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD
To: SUPERGEN, INC.
Reel/Frame 019095/0209 →
Assignment of Assignor's Interest
Nov 8, 2007
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD
To: SUPERGEN, INC.
Reel/Frame 020085/0921 →
Assignment of Assignor's Interest
Mar 28, 2008
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD; XU, YONG
To: SUPERGEN, INC.
Reel/Frame 020721/0348 →
Assignment of Assignor's Interest
May 8, 2008
From: VANKAYALAPATI, HARIPRASAD; LIU, XIAO-HUI; BEARSS, DAVID J.
To: SUPERGEN, INC.
Reel/Frame 020918/0017 →
Assignment of Assignor's Interest
Jul 29, 2008
From: BEARSS, DAVID J.; VANKAYALAPATI, HARIPRASAD; XU, YONG
To: SUPERGEN, INC.
Reel/Frame 021309/0536 →
Assignment of Assignor's Interest
Nov 15, 2011
From: XU, YONG; YUAN, YI; BRENNING, BENJAMIN G.; HO, KOC-KAN
To: SUPERGEN, INC.
Reel/Frame 027230/0779 →
Merger/Name Change
Feb 22, 2012
From: SUPERGEN, INC.
To: ASTEX PHARMACEUTICALS. INC.
Reel/Frame 027747/0334 →
Security Interest
Nov 17, 2016
From: TOLERO PHARMACEUTICALS, INC.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 040362/0884 →
Merger
Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053172/0940 →
Change of Name
Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0718 →
Assignment of Assignor's Interest
Jul 10, 2020
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD; XU, YONG
To: SUPERGEN, INC.
Reel/Frame 053175/0064 →
Assignment of Assignor's Interest
Jul 10, 2020
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD; XU, YONG
To: SUPERGEN, INC.
Reel/Frame 053174/0964 →
Merger
Jul 10, 2020
From: SUPERGEN, INC.
To: ASTEX PHARMACEUTICALS, INC.
Reel/Frame 053174/0873 →
Merger
Jul 16, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053225/0444 →
Change of Name
Jul 16, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053225/0690 →
Assignment of Assignor's Interest
Jul 16, 2020
From: XU, YONG; BRENNING, BENJAMIN G.; KULTGEN, STEVEN G.; LIU, XIAOHUI
To: ASTEX PHARMACEUTICALS, INC.
Reel/Frame 053224/0007 →
Assignment of Assignor's Interest
Jul 16, 2020
From: XU, YONG; BRENNING, BENJAMIN G.; KULTGEN, STEVEN G.; LIU, XIAOHUI
To: ASTEX PHARMACEUTICALS, INC.
Reel/Frame 053224/0075 →
Corrective Assignment to Correct the Receiving Party Name Previously Recorded on Reel 053225 Frame 0444. Assignor(S) Hereby Confirms the Merger.
Jul 17, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053242/0090 →
Assignment of Assignor's Interest
Jul 22, 2020
From: BEARSS, DAVID J.; VANKAYALAPATI, HARIPRASAD; XU, YONG
To: SUPERGEN, INC.
Reel/Frame 053279/0690 →
Merger
Jul 24, 2020
From: SUPERGEN, INC.
To: ASTEX PHARMACEUTICALS, INC.
Reel/Frame 053300/0930 →
Change of Name
Jul 28, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053325/0735 →
Merger
Jul 28, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053325/0542 →
Change of Name
Apr 25, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059787/0758 →
Merger
Sep 18, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068618/0375 →